Invention Publication
- Patent Title: TREATMENT OF MOST BOTHERSOME SYMPTOM (MBS) ASSOCIATED WITH MIGRAINE USING ANTI-CGRP ANTIBODIES
-
Application No.: US18182822Application Date: 2023-03-13
-
Publication No.: US20240101653A1Publication Date: 2024-03-28
- Inventor: Roger K. Cady , Jeffrey T.L. Smith , Joseph Hirman
- Applicant: H. Lundbeck A/S
- Applicant Address: DK Valby
- Assignee: H. Lundbeck A/S
- Current Assignee: H. Lundbeck A/S
- Current Assignee Address: DK Valby
- Main IPC: C07K16/18
- IPC: C07K16/18 ; A61K9/00 ; A61P25/06
Abstract:
Methods for treatment of most bothersome symptom (MBS) associated with migraine are provided. Exemplary methods provide improvement in MBS associated with migraine within 1 month of administration og anti-CGRP antibodies of the invention. Also provided are methods for improvement of patient impression of change (PGIC) associated with migraine. Exemplary methods comprise administration of an anti-CGRP antagonistic antibody to a patient in need thereof.
Information query
